Epstein David, Mason Anne, Manca Andrea
Centre for Health Economics, University of York, UK.
Health Econ. 2008 Jan;17(1 Suppl):S21-31. doi: 10.1002/hec.1329.
Stroke is a major cause of mortality and morbidity, but the reasons for differences in costs of care within and between countries are not well understood. The HealthBASKET project used a vignette methodology to compare the mean costs and prices of hospital care across providers in nine European Union countries. Data on resource use, unit costs and prices of care for female stroke patients without co-morbidity were collected from a sample of 50 hospitals. Mean costs for each provider were analysed using multiple regression. Sensitivity analysis explored the effects on cost of using official exchange rates, purchasing power parity (PPP) and proportion of national income per capita. The mean cost of a hospital episode per patient for stroke at PPP was 3813 euros (standard error 227) with an additional day in hospital typically associated with 6.9% (95% CI: 4-9%) higher costs and thrombolysis associated with 41% higher costs (10-73%). After adjusting for explanatory factors, about 76% of the variation in cost could be attributed to between-country differences, and the extent of this variation was sensitive to the method of currency conversion. There was considerable variation in the care pathways within and between countries, including differences in the availability of stroke units and access to rehabilitative services, but only the length of stay and use of thrombolytic therapy were significantly associated with higher cost. The vignette methodology appears feasible, but further research needs to consider access to healthcare over a longer follow up and to include both costs and outcomes.
中风是导致死亡和发病的主要原因,但各国国内以及不同国家之间护理成本存在差异的原因尚未得到充分理解。“健康篮子”项目采用了案例法,比较了欧盟九个国家不同医疗机构中风护理的平均成本和价格。从50家医院的样本中收集了无合并症女性中风患者的资源使用、单位成本和护理价格数据。使用多元回归分析了每个医疗机构的平均成本。敏感性分析探讨了使用官方汇率、购买力平价(PPP)和人均国民收入比例对成本的影响。按购买力平价计算,每位中风患者每次住院的平均成本为3813欧元(标准误差227),住院天数每增加一天,成本通常会高出6.9%(95%置信区间:4-9%),溶栓治疗则会使成本高出41%(10-73%)。在对解释因素进行调整后,约76%的成本差异可归因于国家间差异,且这种差异的程度对货币换算方法敏感。各国国内以及不同国家之间的护理路径存在很大差异,包括中风单元的可及性和康复服务的获取方面的差异,但只有住院时间和溶栓治疗的使用与较高成本显著相关。案例法似乎可行,但进一步的研究需要考虑在更长的随访期内的医疗服务可及性,并纳入成本和结果。